摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-2-Vinyl-cyclopropancarbonsaeuremethylester | 160022-45-7

中文名称
——
中文别名
——
英文名称
cis-2-Vinyl-cyclopropancarbonsaeuremethylester
英文别名
Methyl (1R,2R)-2-vinylcyclopropane-1-carboxylate;methyl (1R,2R)-2-ethenylcyclopropane-1-carboxylate
cis-2-Vinyl-cyclopropancarbonsaeuremethylester化学式
CAS
160022-45-7
化学式
C7H10O2
mdl
——
分子量
126.155
InChiKey
NIKRQZZKLVNECO-NTSWFWBYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    cis-2-Vinyl-cyclopropancarbonsaeuremethylester二异丁基氢化铝 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 以70%的产率得到cis-2-Vinylcyclopropanmethanol
    参考文献:
    名称:
    Controlling π-Facial Diastereoselectivity in the 1,3-Dipolar Cycloadditions of Diazomethane to Chiral Pentenoates and Furanones:  Enantioselective Stereodivergent Syntheses of Cyclopropane Hydroxy Acids and Didehydro Amino Acids
    摘要:
    The title compounds have been synthesized in both enantiomeric forms and in good overall yields by using D-glyceraldehyde as the single chiral precursor. The efficiency and usefulness of the synthetic routes have been secured by performing controlled manipulations of the functional groups and by highly stereoselective transformations, namely Wittig-Horner condensations and cyclopropanations. Cyclopropane derivatives have been synthesized through 1,3-dipolar cycloaddition of diazomethane to chiral pentenoates or furanones obtained, in turn, from D-glyceraldehyde. Syn/anti stereochemistry of the cycloadducts has been unequivocally assigned and rationalized. Since pi-facial diastereoselectivity involved in these cycloadditions is the opposite for cyclic and open-chain structures, enantiomeric series of products can be derived.
    DOI:
    10.1021/jo972219a
  • 作为产物:
    描述:
    参考文献:
    名称:
    Controlling π-Facial Diastereoselectivity in the 1,3-Dipolar Cycloadditions of Diazomethane to Chiral Pentenoates and Furanones:  Enantioselective Stereodivergent Syntheses of Cyclopropane Hydroxy Acids and Didehydro Amino Acids
    摘要:
    The title compounds have been synthesized in both enantiomeric forms and in good overall yields by using D-glyceraldehyde as the single chiral precursor. The efficiency and usefulness of the synthetic routes have been secured by performing controlled manipulations of the functional groups and by highly stereoselective transformations, namely Wittig-Horner condensations and cyclopropanations. Cyclopropane derivatives have been synthesized through 1,3-dipolar cycloaddition of diazomethane to chiral pentenoates or furanones obtained, in turn, from D-glyceraldehyde. Syn/anti stereochemistry of the cycloadducts has been unequivocally assigned and rationalized. Since pi-facial diastereoselectivity involved in these cycloadditions is the opposite for cyclic and open-chain structures, enantiomeric series of products can be derived.
    DOI:
    10.1021/jo972219a
点击查看最新优质反应信息

文献信息

  • [EN] MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES<br/>[FR] INHIBITEURS MACROCYCLIQUES DE PEPTIDYLARGININE DÉIMINASES
    申请人:GILEAD SCIENCES INC
    公开号:WO2021222353A1
    公开(公告)日:2021-11-04
    The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.
    本公开涉及用于治疗与肽精酸脱亚酶(PADs)相关的疾病的新化合物,例如肽精酸脱亚酶类型4(PAD4)。本公开还涉及用于制备这些化合物的过程和中间体,使用这些化合物的方法以及包含所述化合物的药物组合物。
  • Enantioselectivity and<i>cis</i>/<i>trans</i>-Selectivity in Dirhodium(II)-Catalyzed addition of diazoacetates to olefins
    作者:Paul Müller、Corine Baud、Doïna Ené、Sharokh Motallebi、Michael P. Doyle、Bridget D. Brandes、Alexey B. Dyatkin、Marjorie M. See
    DOI:10.1002/hlca.19950780217
    日期:1995.3.22
    comparable. Additions catalyzed by 1 are strongly sensitive to steric effects. Highly substituted olefins afford cyclopropanes in only poor yield. The preferential cis-selectivity observed in reactions catalyzed by 1 is attributed to dominant interactions between the ligand of the catalyst and the substituents of both olefin and diazoacetate, which overrule the steric interactions between olefin and diazoacetate
    用[Rh 2 (4 S)-phox} 4 ](1 ; phox =四[[4 S)-四氢-4-苯基恶唑-2-酮])研究了Rh 11催化的重氮乙酸酯类化合物向烯烃的加成反应。,[Rh 2 ((2 S)-mepy} 4 ](2 ; mepy =四[甲基(2 S)-四氢-5-氧杂吡咯-2-羧酸酯])和[Rh 2(OAc)4 ](3)。当用2和3催化时,优先提供反式-环丙烷羧酸酯,顺式-异构体是1的主要产品。通常,用1和2获得的对映选择性是可比较的。1催化的加成对位阻效应非常敏感。高度取代的烯烃仅以较差的收率提供环丙烷。在1催化的反应中观察到的优先顺式选择性归因于催化剂的配体与烯烃和重氮乙酸酯的取代基之间的显性相互作用,该相互作用抵消了烯烃和重氮乙酸酯在过渡态下的卡宾转移的空间相互作用。
  • New catalytic system Cu(OAc)2—2,4-lutidine—ZnCl2 for olefin cyclopropanation with methyl diazoacetate
    作者:V. F. Gareev、R. M. Sultanova、R. Z. Biglova、V. A. Dokichev、Yu. V. Tomilov
    DOI:10.1007/s11172-008-0238-x
    日期:2008.8
    A new efficient catalytic system consisting of Cu(OAc)2, 2,4-lutidine, and ZnCl2 was found for the cyclopropanation of unsaturated compounds with methyl diazoacetate. In the case of conjugated dienes, the process occurs regioselectively at the most alkylated C=C bond.
    发现了一种由 Cu(OAc)2、2,4-二甲基吡啶和 ZnCl2 组成的新型高效催化体系,用于不饱和化合物与重氮乙酸甲酯环丙烷化反应。对于共轭二烯,该过程区域选择性地发生在烷基化程度最高的 C=C 键处。
  • Stereoselective synthesis of enantiopure cyclopropane didehydroamino acid derivatives: (−)-(Z)-2-Benzyloxycarbonylamino-4,5-cyclopropane-2-hexenodioic acid dimethyl ester
    作者:Neuh Hanafi、Rosa M. Ortuño
    DOI:10.1016/0957-4166(94)80074-x
    日期:1994.9
    The title amino acid derivative has been synthesized stereoselectively in 40% overall yield from 5-tert-butyldiphenylsilyloxymethyl-2(5H)-furanone used as a chiral precursor.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸